Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP manufacturing agreement
10-Feb-2010 -
Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient (API) for Vitae's lead product candidate, VTP-27999. Solvias will provide ongoing process R&D support and deliver the VTP-27999 API, produced ...
active pharmaceutical ingredients
clinical trials
hypertension
+4